Digital therapeutics world first for Big Health in ScotlandUK-based Big Health has passed a digital health milestone after Scotland became the first country to make anxiety Share XDigital therapeutics world first for Big Health in Scotlandhttps://pharmaphorum.com/news/digital-therapeutics-world-first-big-health-scotland/
Consternation as NICE rejects Janssen MS drug PonvoryNICE has delivered its first verdict on NHS funding of Janssen’s oral multiple sclerosis drug Ponvory, and it’s Share XConsternation as NICE rejects Janssen MS drug Ponvoryhttps://pharmaphorum.com/news/consternation-as-nice-rejects-janssen-ms-drug-ponvory/
NICE clears NHS use of Roche’s Tecentriq in bladder cancerNICE has recommended routine NHS access to Roche’s cancer immunotherapy Tecentriq for some bladder cancer patients, four years Share XNICE clears NHS use of Roche’s Tecentriq in bladder cancerhttps://pharmaphorum.com/news/nice-clears-nhs-use-of-roches-tecentriq-in-bladder-cancer/
Early detection of cancers will require blood sweat and tearsAn NHS study of a new cancer blood test holds huge promise, but will not be without its Share XEarly detection of cancers will require blood sweat and tearshttps://pharmaphorum.com/r-d/galleri-test-nhs-early-detection-cancers/
Keytruda backed by NICE for late-stage oesophageal cancerMSD’s Keytruda has become the first immunotherapy cleared by NICE for previously-untreated patients with advanced oesophageal cancer, making Share XKeytruda backed by NICE for late-stage oesophageal cancerhttps://pharmaphorum.com/news/keytruda-backed-by-nice-for-late-stage-oesophageal-cancer/
Taking stock of NHS medicines optimisationGiven the rising cost of medicines as a share of the NHS budget in England, the establishment of Share XTaking stock of NHS medicines optimisationhttps://pharmaphorum.com/patients/nhs-confederation-medicines-optimisation-ics/
NHS England starts largest ever trial of Galleri cancer blood testA blood test called Galleri that could detect dozens of different forms of cancer before symptoms appear will Share XNHS England starts largest ever trial of Galleri cancer blood testhttps://pharmaphorum.com/news/nhs-england-starts-largest-ever-trial-of-galleri-cancer-blood-test/
NHS fast tracks access to Amgen’s just-approved KRAS cancer drugAmgen’s first-in-class KRAS inhibitor Lumykras has been approved in Great Britain and arrives already armed with an agreement Share XNHS fast tracks access to Amgen’s just-approved KRAS cancer drughttps://pharmaphorum.com/news/nhs-fast-tracks-access-to-amgens-just-approved-kras-cancer-drug/
AZ CEO Soriot urges caution on COVID booster dosesThe UK should think twice before backing widespread use of COVID-19 booster vaccinations, as to do so could Share XAZ CEO Soriot urges caution on COVID booster doseshttps://pharmaphorum.com/news/az-ceo-soriot-urges-caution-on-covid-booster-doses/
